Active Implantable Medical Devices Market Beauty Devices Market Latest Trends, Analysis & Insights

1
Global Active Implantable Medical Devices Market
to Witness 8 CAGR during 2017 2023
2
Global Active Implantable Medical Devices Market
According to a new market research report Global
Active Implantable Medical Devices Market Size,
Share, Development, Growth and Demand Forecast to
2023 - Industry Insight by Product (Implantable
Cardioverter Defibrillators, Neurostimulators,
Implantable Cardiac Pacemakers, Implantable
Hearing Devices, Ventricular Assist Devices,
Implantable Heart Monitors/Insertable Loop
Recorders) published by PS Market Research, the
global Active Implantable Medical Devices market
is projected to reach 28,878.6 million by 2023,
growing at a CAGR of 8.0 during 2017 -
2023. Access Report Description at
https//www.psmarketresearch.com/market-analysis/a
ctive-implantable-medical-devices-market
3
Global Active Implantable Medical Devices Market
Global active implantable medical devices market
was worth 16,990.8 million in 2016
According to the study, the global active
implantable medical devices market is likely to
grow from 17.0 billion in 2016 to 28.9 billion
by 2023. Technological advancements, increasing
prevalence of cardiovascular diseases, rising
healthcare expenditures and increasing research
and development activities have been driving the
growth of the global active implantable medical
devices market. The market is further expected to
gain revenue due to increasing geriatric
population and incidence of neurological
disorders. Development of subcutaneous
implantable cardioverter defibrillators along
with the increasing demand from developing
nations is expected to create ample growth
opportunities in the global active implantable
medical devices market.
4
Global Active Implantable Medical Devices Market
Insights on market segments
As per the findings of research, implantable
cardioverter defibrillators held the largest
share in the global active implantable medical
devices market in 2016, primarily due to the
development of technologically advanced devices
and increasing prevalence of cardiovascular
diseases. The neurostimulators market is expected
to witness the highest growth during the forecast
period. This growth of neurostimulators is
attributed to the increasing incidence of
neurological disorders and increasing demand from
emerging economies. Among different type of
implantable cardioverter defibrillators,
transevenous implantable cardioverter
defibrillators held larger share in the global
active implantable medical devices market in
2016, and it is also expected to witness higher
growth during the forecast period. Increasing
research and development activities and rising
compliance for technological innovations and data
driven customizations are driving the growth of
the global transvenous implantable cardioverter
market. Among different types of
neurostimulators, spinal cord stimulators
contributed the largest revenue to the global
neurostimulators market in 2016. Spinal cord
stimulators market witnessed significant
penetration across all geographies globally.
Increasing number of failed-back surgery
syndrome, refractory angina pectoris, peripheral
vascular disease, and complex regional pain
syndrome are the key factors leading to the
increased demand for spinal cord stimulators.
5
Global Active Implantable Medical Devices Market
North America stands as the largest active
implantable medical devices market
Geographically, North America has been the
largest market for active implantable medical
devices, with the U.S. being the larger
contributor to the regional market as compared to
Canada. The key factor driving the North American
active implantable medical devices market are
technological advancements, high healthcare
expenditure, growing geriatric population,
improved healthcare infrastructure and growing
prevalence of cardiovascular diseases. The
emerging economies in Asia-Pacific, especially
China and India, are expected to grow
tremendously in future, which is expected to
bring the Asia-Pacific market approximately equal
to the European market by 2023. Asia-Pacific
presents several growth opportunities for the
active implantable medical devices manufacturers
due to the rapid expansion of healthcare industry
in the region.
6
Global Active Implantable Medical Devices Market
Increasing adoption of neurostimulation
technology to have high impact on the global
active implantable medical devices market
Neurostimulation technology involves the usage of
microelectrodes to activate nerves in the nervous
system. A neurostimulation device is powered by
battery and is a stopwatch sized device. It is
surgically implanted in the brain and helps in
generating paresthesia, a tingling sensation at
the scheduled time intervals to the nervous
system. These electric signals develop a
sensation in the damaged nerves and help in
treating chronic pain and neurological disorders.
In case of chronic pain conditions, these
electrical signals help in blocking the pain
messages from nerves to reach brain. These
devices are generally used in cases, where drug
therapies are not effective. Increasing incidents
of neurological disorders and the rising demand
for minimally invasive procedures are leading to
the increased demand for neurostimulators. The
rapid penetration of neurostimulators market in
the emerging economies is expected to have
significant impact on the growth of the global
active implantable medical devices market.
7
Global Active Implantable Medical Devices Market
Acquisition, a major development strategy for key
players to strengthen their position in the
global market
Key companies in the active implantable medical
devices market are acquiring other companies to
strengthen their position in the global market.
In January 2017, Abbott completed the acquisition
of St. Jude Medical, Inc., including its atrial
fibrillation, structural heart and heart failure
business as well as neuromodulation business.
Similarly, in January 2015, Medtronic plc
completed the acquisition of Covidien plc. Under
the terms of the acquisition agreement,
Medtronic, Inc. and Covidien plc are now combined
under Medtronic plc. The acquisition strengthened
position of the company in the global market with
a large number of product offerings. Some of the
other key players in the market include Boston
Scientific Corporation, BIOTRONIK SE Co. KG,
LivaNova PLC, William Demant Holding A/S,
Nurotron Biotechnology Co. Ltd., Sonova Holding
AG, and MED-EL.
8
Global Active Implantable Medical Devices Market
Download report sample at
https//www.psmarketresearch.com/market-analysis/a
ctive-implantable-medical-devices-market/report-sa
mple
9
GET IN TOUCH
THANK YOU!
For information regarding permissions and other
queries Kindly write to
US/Canada Toll-Free 1-888-778-7886